Skip to main content

Vitamin E, Cognitive Decline, and MyPlate

A number of avenues have been taken to study the treatment of age-related cognitive decline/impairment (think diseases like Alzheimer's Disease). Nutrition has gotten a lot of focus, with studies looking at Omega 3 fatty acid intake and fruit and vegetable consumption (even in the form of juices) potentially lowering the risk of Alzheimer's Disease (AD) and protecting against cognitive decline (1,2,3).

Another major area for nutrition in the prevention of cognitive decline (and seemingly most age-related diseases) has looked into mitigating oxidative stress - a major factor in the pathogenesis of Alzheimer's Disease is the oxidative up-regulation of beta and gamma secretase, required for the generation of beta-amyloid plaques (4). There are other components of the disease including the ApoE4 genotype (6), as well as advanced glycated end products and blood brain barrier permeability but I won't discuss that at the moment - though it's good to know that the latter is a major component and is why some call Alzheimer's type 3 Diabetes.

If oxidative stress is an issue, it stands to reason that antioxidants may have some therapeutic effect. Unfortunately, past research looking at vitamin E wasn't overly promising (5). However, a couple new studies came out recently with more promising results - one in JAMA (7) that showed 2000 IU/day (500IU above the set Upper Limit - practically unattainable consuming foods) supplementation of alpha-tocopherol slowed cognitive function's decline; the other in Experimental Gerontology (EG) (8) that looked at serum markers of both tocopherols and tocotrienols, markers of oxidative damage and cognitive impairment, showed that those older adults with elevated serum levels of tocopherols and tocotrienols at baseline were protected against cognitive impairment 8 years later (while they did their best to control statistically for confounding variables, they still can't say that individuals continued to have elevated serum Vitamin E levels beyond baseline measurements).

From these studies, there's 3 things I'd like to point out:
1. Vitamin E is not one chemical - I've said this before. Though the JAMA article saw positive effects to alpha tocopherol, the medical community has largely only paid attention to form of Vitamin E, ignoring the other 7 components in the vitamin E complex. The authors in (8) note that other Vitamin E metabolites likely have protective effects and need more consideration - their study built on another cohort Swedish cohort that also looked at all 8 forms of vitamin E and found similar results regarding the importance the whole vitamin E complex (9).
2. Treatment vs Habitual Consumption - these studies are a good examples of the difference between treatment and preventative medicine. The JAMA study looked at those with mild to moderate AD and began treatment with high doses of vitamin E. The EG study followed individuals who began with no known cognitive impairments and followed up with individuals 8 years later. The JAMA study employed a large vitamin E supplement as treatment, whereas the EG study measured the effectiveness of maintaining regular higher serum levels of Vitamin E (assuming baseline values were reflective of habitual intakes) in reducing cognitive decline. Both warrant further research and show some promise for Vitamin E's role as both a preventative measure and treatment for age-related cognitive decline.
3. Where's the E in our Diet ??- after the 'i' and before the 't' is the only good answer there. Or at least, if you look at MyPlate, it would appear so. My biggest beef with MyPlate is that there's no place for nuts and seeds - the best and most health-promoting way to get your vitamin E (yes, there are other sources, but nowhere near as potent as nuts/seeds). You'll be hard pressed to find any evidence that suggests regular nut and seed consumption of 1-2 servings a day is detrimental. Yet the plate is missing a category that they fit into well - some will argue protein, but every time i've seen the table presented, it always states lean protein; and a serving in the old pyramid was 1 tbsp of nut butter as a protein food (about 3.5g of protein ??). The plate needs some reworking.

For now, it seems that high doses of vitamin E might play a beneficial role in delaying cognitive impairment for those with mild to moderate, and moderately severe Alzheimer's Disease - however, for clinicians, benefits need to be weighed against symptoms of hypervitaminosis E (increased hemorrhaging-already a potential worry for the older population) , and associations between Vitamin E supplementation and all-cause mortality (10). It also appears that regularly consuming dietary sources of both tocopherols and tocotrienols has an appreciable effect on delaying the onset of Alzheimer's symptoms. More research needs to be undertaken, looking at more time points, and in an age range less close to the onset of Alzheimer's.

Let's get more nuts and seeds back into the diet! They're not only great for vitamin E, but for slowing down digestion of carbohydrates, potentially protecting against insulin resistance/diabetes, another major risk factor for AD (11).

1. http://www.ncbi.nlm.nih.gov/pubmed/16216930
2. http://www.ncbi.nlm.nih.gov/pubmed/12873849
3. http://www.ncbi.nlm.nih.gov/pubmed/16945610
4. http://www.ncbi.nlm.nih.gov/pubmed/21901428
5. http://www.ncbi.nlm.nih.gov/pubmed/18469254
6. http://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-genetics-fact-sheet
7. http://jama.jamanetwork.com/article.aspx?articleid=1810379
8. http://www.ncbi.nlm.nih.gov/pubmed/24113154
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738400/
9. http://www.ncbi.nlm.nih.gov/pubmed/20413888
10. http://www.ncbi.nlm.nih.gov/pubmed/21235492
11. http://www.ncbi.nlm.nih.gov/pubmed/21787319

Comments

Popular posts from this blog

Beware the Meta-Analysis: Fat, Guidelines, and Biases

Headlines were abuzz this week, reporting that a new review of randomized controlled trials at the time of the low-fat guidelines didn't support their institution. Time , Business Insider , and The Verge all covered the topic with sensationalist headlines (e.g. 'We should never have told people to stop eating fat' #weneverdid). I won't spend every part of this blog picking apart the entire meta-analysis; you can read it over at the open access journal, BMJ Open Heart (1) -- (note, for myself, i'm adding an extra level of skepticism for anything that gets published in this journal). I'm also not going to defend low-fat diets either, but rather, use this meta-analysis to point out some critical shortcomings in nutritional sciences research, and note that we should be wary of meta-analyses when it comes to diet trials. First off, let's discuss randomized controlled trials (RCTs). They are considered the gold standard in biomedical research; in the hierarc...

On PURE

The PURE macronutrients studies were published in the Lancet journals today and the headlines / commentaries are reminding us that everything we thought we think we were told we knew about nutrition is wrong/misguided, etc. Below is my non-epidemiologist's run down of what happened in PURE. A couple papers came out related to PURE, but the one causing the most buzz is the relationship of the macronutrients to mortality. With a median follow up of 7.4 years, 5796 people died and 4784 had a major cardiovascular event (stroke, MCI). The paper modeled the impacts of self reported dietary carbohydrate, total fat, protein, monounsaturated (MUFA), saturated (SFA), and polyunsaturated (PUFA) fatty acid intakes on cardiovascular (CVD), non-CVD and total mortality; all macros were represented as a percentage of total self reported energy intakes and reported/analyzed in quintiles (energy intakes between 500-5000kcals/day were considered plausible..). All dietary data was determined by a ...

The Singling Out of Golden Rice

I saw earlier today that  Steven Novella, MD, over at Neurlogica blog  covered some controversy surrounding Golden Rice and it reminded me I had some thoughts to throw down about the GR issue. Dr Novella's post was in response to some of the claims made in a comment written on his post about a recent Nature Biotechnology paper on crop biofortification .  This is an area I've seen a lot of commentary on, no doubt because Golden Rice is a transgenic crop. Dr Novella makes some good commentary in his post and I suggest reading it ( here ) before the rest of this post - it will contain some additional thoughts to Dr Novella's. Dr Novella did a great job fielding the opposition to Golden Rice, which is something I've always found rather odd - I guess if you're vehemently opposed to a technology that represents a diverse array of methods (there's not one way to genetically engineer a plant) and innumerable potential outcomes (plants can be engineered for any number ...